Investigation of a Customized Femoral Resurfacing Implant — Knee100

Articular Cartilage Disorder Clinical Trial

Official title:
Investigation of a Customized Femoral Resurfacing Implant (Episealer® Knee Condyle Device) to Assess the Safety Profile and Performance for 2 Years Post-operatively

Status Completed

Clinical Trial Summary

The purpose is to assess the safety profile and performance of a femoral resurfacing implant for localized chondral lesions.

Clinical Trial Description

The implant's safety profile will be assessed by incidence of any subject having any of the seven identified implant-related clinical undesirable side effects. This will be analyzed with a one-side exact binomial test on significance level 0.05, at 24 months post-operatively. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01690689
Study type	Interventional
Source	Episurf Medical Inc.
Contact
Status	Completed
Phase	N/A
Start date	December 2012
Completion date	March 31, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05424848` - Femoral Cartilage Thickness in Parkinson's Disease
Terminated	`NCT01400607` - Neocartilage Implant to Treat Cartilage Lesions of the Knee	Phase 3
Terminated	`NCT01410136` - Chondrofix Osteochondral Allograft Prospective Study	N/A